Hempstract (OTCMKTS:HPST – Get Free Report) and Anadarko Petroleum (NASDAQ:APC – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations.
Volatility and Risk
Hempstract has a beta of 1.78, meaning that its share price is 78% more volatile than the S&P 500. Comparatively, Anadarko Petroleum has a beta of 1.64, meaning that its share price is 64% more volatile than the S&P 500.
Earnings & Valuation
This table compares Hempstract and Anadarko Petroleum”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Hempstract | N/A | N/A | N/A | N/A | N/A |
| Anadarko Petroleum | $5.58 billion | 0.04 | $615.00 million | $0.43 | 46.35 |
Anadarko Petroleum has higher revenue and earnings than Hempstract.
Profitability
This table compares Hempstract and Anadarko Petroleum’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Hempstract | N/A | N/A | N/A |
| Anadarko Petroleum | -4.20% | 10.49% | 2.68% |
Analyst Ratings
This is a summary of recent recommendations for Hempstract and Anadarko Petroleum, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Hempstract | 0 | 0 | 0 | 0 | 0.00 |
| Anadarko Petroleum | 1 | 2 | 3 | 1 | 2.57 |
Anadarko Petroleum has a consensus price target of $21.60, indicating a potential upside of 8.38%. Given Anadarko Petroleum’s stronger consensus rating and higher possible upside, analysts plainly believe Anadarko Petroleum is more favorable than Hempstract.
Institutional & Insider Ownership
85.2% of Anadarko Petroleum shares are owned by institutional investors. 28.1% of Hempstract shares are owned by company insiders. Comparatively, 0.5% of Anadarko Petroleum shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Anadarko Petroleum beats Hempstract on 8 of the 11 factors compared between the two stocks.
About Hempstract
Hempstract, Inc. produces and sells cannabidiol (CBD) and cannabigerol solutions in the United States. It offers CBD isolate powder and distillate oil. The company was formerly known as Riverdale Oil and Gas Corporation and changed its name to Hempstract, Inc. in November 2020. Hempstract, Inc. is based in Warden, Washington.
About Anadarko Petroleum
Anadarko Petroleum Corporation engages in the exploration, development, production, and marketing of oil and gas properties. It operates through three segments: Exploration and Production, WES Midstream, and Other Midstream. The company explores for and produces oil, natural gas, and natural gas liquids (NGLs). It is also involved in gathering, processing, treating, and transporting oil, natural-gas, and NGLs production, as well as the gathering and disposal of produced water. The company's oil and natural gas properties are located in the United States onshore and deepwater Gulf of Mexico; and Algeria, Ghana, Mozambique, Colombia, Peru, and other countries. As of December 31, 2018, it had approximately 1.5 billion barrels of oil equivalent of proved reserves. The company was founded in 1959 and is headquartered in The Woodlands, Texas.
Receive News & Ratings for Hempstract Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hempstract and related companies with MarketBeat.com's FREE daily email newsletter.
